Human Papilloma Virus and Esophageal Squamous Cell Carcinoma
Human papilloma virus (HPV) has been suggested as an etiology of esophageal squamous cell carcinoma (SCC). The aim of this study was to investigate the prevalence of HPV infection in esophageal SCCs in our region with strict contamination control to prevent false positive results. Thirty cases of esophageal squamous cell carcinomas were chosen by simple random selection in a period of two years. PCR for target sequence of HPV L1 gene was performed on nucleic acid extracted from samples by means of GP5+/GP6+ primers. All tissue samples in both case and control groups were negative for HPV-DNA. Although the number of cases in this study was limited, the contribution of HPV in substantial number of esophageal SCCs in our region is unlikely.
Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83(10):2049-53.
Muñoz N, Day NE. Esophageal cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. 2006, Oxford University Press, USA
Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cncer 1999;80(6):827-41.
Holmes RS, Vaughan TL. Epidemiology and pathogenesisof esophageal cancer. Semin Radiat Oncol 2007;17(1):2-9.
Valsecchi MG. Modelling the relative risk of esophageal cancer in a case-control study. J ClinEpidemiol 1992;45(4):347-55.
Turner JR, Shen LH, Crum CP, Dean PJ, Odze RD. Low prevalence of human papillomavirus infection inesophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specificpolymerase chain reaction-based approach. Humanpathology 1997;28(2):174-8.
Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Reviews Cancer 2002;2(5):342-50.
Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32 Suppl 1:S7-15..
Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, LuC, Kim H, Axelrod R,Silverman CC, Redmond KP, Gillison ML. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363(1):24-35.
Schlencht NF. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence. Oncol Rep 2005;14(5):1239-47.
Far AE, Aghakhani A, Hamkar R, Ramezani A, PishbigarHF, Mirmomen S, Roshan MR, Vahidi S, ShahnaziV, Deljoodokht Z. Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma inIranian patients. Scand J Infect Dis 2007;39(1):58-62..
Moberg M, Gustavsson I, Gyllensten U. Real-time PCRbased system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41(7):3221-8.
Shahsiah R, Khademalhosseini M, Mehrdad N, RamezaniF, Nadji SA. Human papillomavirus genotypes in Iranianpatients with cervical cancer. Pathol Res Pract 2011;207(12):754-7.
Evans MF, Adamson CS, Simmons-Arnold L, Cooper K.Touchdown General Primer (GP5+/GP6+) PCR andoptimized sample DNA concentration support the sensitivedetection of human papillomavirus. BMC Clin Pathol 2005;5:10.
Castillo A, Aguayo F, Koriyama C, Torres M, Carrascal E, Corvalan A, Roblero JP, Naquira C, Palma M, Backhouse C, Argandona J,Itoh T, Shuyama K, Eizuru Y, Akiba S. Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World JGastroenterol 2006;12(38):6188-92.
Shuyama K, Castillo A, Aguayo F, Sun Q, Khan N, Koriyama C, Akiba S. Human papillomavirus in highand low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007;96(10):1554-9.
Souto Damin AP, Guedes Frazzon AP, de Carvalho Damin D, Beck Biehl H, Abruzzi de Oliveira L, Auler R, Marroni C, Alexandre CO. Detection of human papillomavirus,DNA in squamous cell carcinoma of the esophagus by autonested PCR. Dis Esophagus 2006;19(2):64-8.
Takahashi A, Ogoshi S, Ono H, Ishikawa T, Toki T, Ohmori N, Iwasa M, Iwasa Y, Furihata M, Ohtsuki Y. High-risk human papillomavirus infection andoverexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan. Dis Esophagus 1998;11(3):162-7..
Kamath AM, Wu TT, Heitmiller R, Daniel R, Shah KV. Investigation of the association of esophageal carcinomawith human papillomaviruses. Dis Esophagus 2000;13(2):122-4.
Koshiol J, Wei WQ, Kreimer AR, Chen W, Gravitt P, RenJS, Abnet CC, Wang JB, Kamangar F, Lin DM, vonKnebel-Doeberitz M, Zhang Y, Viscidi R, Wang GQ, Gillison ML, Roth MJ, Dong ZW, Kim E, Taylor PR, Qiao YL, Dawsey SM. No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010;127(1):93-100.
Baseman JG, Koutsky LA. The epidemiology of humanpapillomavirus infections. J Clin Virol 2005;32 Suppl 1:S16-24.
Molijn A, Kleter B, Quint W, van Doorn LJ. Molecular diagnosis of human papillomavirus (HPV) infections. J Clin Virol 2005;32 Supple 1:43-51.
Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. The Lancet 1999;354(9174):218-9.
Rys PN, Persing DH. Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products. J clin microbiol 1993;31(9):2356-60.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.